Nanotechnology for molecular imaging and targeted therapy

Circulation

Volumn 107, Issue 8, 2003, Pages 1092-1095

  Wickline, Samuel A ^a,b   Lanza, Gregory M ^a  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contrast media; Editorials; Imaging

Indexed keywords

CONTRAST MEDIUM; FLUOROCARBON; NANOPARTICLE; PACLITAXEL;

BIOENGINEERING; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG TARGETING; EDITORIAL; GENE SEQUENCE; HUMAN; IMAGING SYSTEM; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MEDICAL RESEARCH; MOLECULAR BIOLOGY; NANOTECHNOLOGY; PRIORITY JOURNAL;

CARDIOVASCULAR DISEASES; CONTRAST MEDIA; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; MAGNETIC RESONANCE IMAGING; NANOTECHNOLOGY; ULTRASONOGRAPHY;

EID: 0037418161     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000059651.17045.77     Document Type: Editorial

References (36)

1. Allport JR, Weissleder R. In vivo imaging of gene and cell therapies. Exp Hematol. 2001;29:1237-1246.
2. Blankenberg FG, Strauss HW. Noninvasive strategies to image cardiovascular apoptosis. Cardiol Clin. 2001;19:165-172.
3. Bengel FM, Anton M, Avril N, et al. Uptake of radiolabeled 2′-fluoro-2′-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging. Circulation. 2000;102:948-950.
4. Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation. 1996;95: 3334-3340.
5. Sipkins DA, Cheresh DA, Kazemi MR, et al. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med. 1998;4:623-626.
6. Demos S, Alkan-Onyuksel H, Kane B, et al. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Coll Cardiol. 1999;33:867-875.
7. Wiener C, Brechbiel MW, Brothers H, et al. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med. 1994;31:1-8.
8. Bryant LHJ, Brechbiel MW, Wu C, et al. Synthesis and relaxometry of high-generation (G=5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. J Magn Reson Med. 1999;9:348-352.
9. Bulte JW, Zywicke H, Frank JA, et al. Gd-CCMV: potential of paramagnetic viral particles as drug container and MR contrast agent. Molecular Imaging. 2001;1:225.
10. Noon WH, Kong Y, Ma J. Molecular dynamics analysis of a buckyball-antibody complex. Proc Natl Acad Sci U S A. 2002;99:6466-6470.
11. Roessler BJ, Bielinska AU, Janczak K, et al. Substituted beta-cyclodextrins interact with PAMAM dendrimer-DNA complexes and modify transfection efficiency. Biochem Biophys Res Commun. 2001; 283:124-129.
12. Ma Q, Remsen EE, Kowalewski T, et al. Two-dimensional, shell-cross-linked nanoparticle arrays. J Am Chem Soc. 2001;123:4627-4628.
13. Lanza GM, Abendschein DR, Hall CH, et al. In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. J Am Soc Echocardiogr. 2000;13:608-614.
14. Yu X, Song S-K, Chen J, et al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med. 2000;44:867-872.
15. 3-targeted nanoparticles. Magn Reson Med. 2000;44:433-439.
16. Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation. 2001;104:1280-1285.
17. Lanza GM, Yu X, Winter PM, et al. Targeted antiproliferative drug delivery to vascular smooth muscle cells with an MRI nanoparticle contrast agent: Implications for rational therapy of restenosis. Circulation. 2002;106:2842-2847.
18. Josephson L, Tung CH, Moore A, et al. High efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem. 1999;10:186-191.
19. Bogdanov A, Lewin M, Weissleder R. Approaches and agents for imaging the vascular system. Adv. Drug Deliv Rev. 1999;37:279-293.
20. Ruehm SG, Corot C, Vogt P, et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001;103:415-422.
21. Bulte JW, Douglas T, Witwer B, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol. 2001;19:1141-1147.
22. Wunderbaldinger P, Josephson L, Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem. 2002;13:264-268.
23. Kang HW, Josephson L, Petrovsky A, et al. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug Chem. 2002;13:122-127.
24. Louie AY, Huber MM, Ahrens ET, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol. 2000;18: 321-325.
25. Lanza GM, Wallace KD, Fischer SE, et al. High frequency ultrasonic detection of thrombi with a targeted contrast system. Ultrasound Med Biol. 1997;23:863-870.
26. Lanza GM, Trousil RL, Wallace KD, et al. In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J Acoust Soc Am. 1998;104:3665-3672.
27. Lanza GM, Abendschein DR, Hall CH, et al. Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest Radiol. 2000;35:227-234.
28. Takeuchi M, Ogunyankin K, Pandian N, et al. Enhanced visualiation of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-480AI): in vivo experimental echocardiographic studies. J Am Soc Echocardiogr. 1999;12:1015-1021.
29. Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 2002;242:121-128.
30. Kolodgie FD, John M, Khurana C, et al. Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel. Circulation. 2002;106:1195-1198.
31. Guzman LA, Labhasetwar V, Song C, et al. Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. Circulation. 1996;94: 1441-1448.
32. Song J, Chappell JC, Qi M, et al. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J Am Coll Cardiol. 2002;39: 726-731.
33. Unger EC, McCreery TP, Sweitzer RH. Ultrasound enhances gene expression of liposomal transfection. Invest Radiol. 1997;32:723-727.
34. Shohet R, Chen S, Zhou YT, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation. 2000;101:2554-2556.
35. Davis SS. Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Ophthalmic Genet. 1997;15:217-224.
36. Åkerman ME, Chan WCW, Laakkonen P, et al. Nanocrystal targeting in vivo. Proc Nat Acad Sci U S A. 2002;99:12617-12621.